RS

Rajendran Selva Balaji

Active Director Director DIN 11903202
DIN 11903202 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajendran Selva Balaji

Rajendran Selva Balaji is a Director at Subbaiah Health Care Private Limited (since 2026).

DIN 11903202
Primary Designation Director
First Appointment 20 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Subbaiah Health Care Private Limited U72100TN2026PTC196928
Director20 Aug 20262026Active

Board colleagues of Rajendran Selva Balaji

NameDINCompanyDesignation
Selvaraj Vidhya11903201Subbaiah Health Care Private LimitedDirector/Designated Partner
Subbaiah Rajendran11926269Subbaiah Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Subbaiah Health Care Private Limited
Premium access

Shareholding and investment profile for Rajendran Selva Balaji

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendran Selva Balaji

Rajendran Selva Balaji currently holds 1 directorship: Subbaiah Health Care Private Limited (Director, since 20 Aug 2026).

Rajendran Selva Balaji was first appointed on 20 Aug 2026 as Director at Subbaiah Health Care Private Limited.

The current boards of Rajendran Selva Balaji's companies include Selvaraj Vidhya (Subbaiah Health Care Private Limited), Subbaiah Rajendran (Subbaiah Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available